| 臺大學術典藏 |
2021-01-06T03:58:41Z |
Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia
|
Hou H.-A.; Shih T.T.F.; Liu C.-Y.; Chen B.-B.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Chou W.-C.; Hsu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:40Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Cheng C.-L.; Hou H.-A.; Jhuang J.-Y.; Lin C.-W.; Chen C.-Y.; JIH-LUH TANG; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:40Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Tseng M.-H.; Huang C.-F.; Tien H.-F.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Lee M.C.; JIH-LUH TANG; Chen C.-Y.; Chou W.-C.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; JIH-LUH TANG; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:38Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Wu S.-J.; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; JIH-LUH TANG; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:38Z |
Intracranial hemorrhage in adult patients with hematological malignancies
|
Chen C.-Y.; Tai C.-H.; Cheng A.; Wu H.-C.; Tsay W.; Liu J.-H.; Chen P.-Y.; Huang S.-Y.; Yao M.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:37Z |
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010
|
Chen C.-Y.; Huang S.-Y.; Tsay W.; Yao M.; JIH-LUH TANG; Ko B.-S.; Chou W.-C.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:37Z |
Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis
|
Chen C.-Y.; Chou W.-C.; Tsay W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:36Z |
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the East
|
Wu S.-J.; Lin C.-T.; Huang S.-Y.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:36Z |
Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
|
Chen C.-Y.; Cheng A.; Huang S.-Y.; Sheng W.-H.; Liu J.-H.; Ko B.-S.; Yao M.; Chou W.-C.; Lin H.-C.; Chen Y.-C.; Tsay W.; JIH-LUH TANG; Chang S.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; JIH-LUH TANG; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; JIH-LUH TANG; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10
|
Chen C.-Y.; Huang S.-Y.; JIH-LUH TANG; Tsay W.; Yao M.; Ko B.-S.; Chou W.-C.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:34Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations
|
Chou S.-C.; JIH-LUH TANG; Hou H.-A.; Chou W.-C.; Hu F.-C.; Chen C.-Y.; Yao M.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
|
Kuo Y.-Y.; Hou H.-A.; Chen Y.-K.; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; JIH-LUH TANG; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12
|
Chen C.-Y.; Sheng W.-H.; Huang S.-Y.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Hou H.-A.; Kuo Y.-Y.; JIH-LUH TANG; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:31Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
Chen Y.-K.; Hou H.-A.; JIH-LUH TANG; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:31Z |
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
|
Cheng C.-L.; Li C.-C.; Hou H.-A.; Fang W.-Q.; Chang C.-H.; Lin C.-T.; JIH-LUH TANG; Chou W.-C.; Chen C.-Y.; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
JIH-LUH TANG; Kung H.-C.; Lei W.-C.; Yao M.; Wu U.-I.; Hsu S.-C.; Lin C.-T.; Li C.-C.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:30Z |
High risk of hepatitis B reactivation among patients with acute myeloid leukemia
|
Chen C.-Y.; Huang S.-Y.; Cheng A.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Sheng W.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F.; Liu C.-W.; Chiang Y.-C.; Liu M.-C.; Huang C.-F.; Tseng M.-H.; Lin L.-I.; Chen C.-Y.; Hou H.-A.; Lin Y.-C.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Liu C.-Y. |
| 臺大學術典藏 |
2021-01-06T03:58:29Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
Huang S.-Y.; Lin H.-H.; Yao M.; JIH-LUH TANG; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma
|
Huang S.-Y.; Lin H.-H.; Lin C.-W.; Li C.-C.; Yao M.; JIH-LUH TANG; Hou H.-A.; Tsay W.; Chou S.-J.; Cheng C.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Liu C.-Y.; Tien H.-F.; Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Li C.-C.; Huang S.-Y.; Yao M.; JIH-LUH TANG; Tsay W. |
| 臺大學術典藏 |
2021-01-06T03:58:28Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Hou H.-A.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:27Z |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tsai C.-H.; Hou H.-A.; JIH-LUH TANG; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Kuo Y.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Tsay W.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008–2013
|
Chen C.-Y.; Tien F.-M.; Sheng W.-H.; Huang S.-Y.; Yao M.; JIH-LUH TANG; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
|
Wang Y.-C.; Kuo S.-H.; Cheng A.-L.; Ma W.-L.; Yao M.; Liao S.-L.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma
|
Wang C.-W.; Hong R.-L.; Tsai C.-L.; Yao M.; JIH-LUH TANG; Lin C.-W.; Cheng A.-L.; Kuo S.-H.; Yang C.W.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:26Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; Liu J.-H.; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; JIH-LUH TANG; Chen Y.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsai C.-H.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:25Z |
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase
|
Yu S.-C.; Huang H.-H.; Li C.-C.; JIH-LUH TANG; Lee Y.-H.; Mao T.-L.; Kuo K.-T.; Lin C.-T.; Liu J.-H.; Ko B.-S.; Yao M. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Hou H.-A.; Tsai C.-H.; Lin C.-C.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Yao M.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
|
Chen C.-Y.; Tien F.-M.; Cheng A.; Huang S.-Y.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tien H.-F.; Sheng W.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:24Z |
Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
|
Lin M.-E.; Hou H.-A.; Tsai C.-H.; Wu S.-J.; Kuo Y.-Y.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:23Z |
Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
|
Cheng C.-L.; Liu J.-H.; Chou S.-C.; Yao M.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:23Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tien F.-M.; Hou H.-A.; Tsai C.-H.; JIH-LUH TANG; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
Tien F.-M.; Hou H.-A.; Tsai C.-H.; JIH-LUH TANG; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:22Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; JIH-LUH TANG; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
|
Lin C.-T.; Hsueh P.-R.; Wu S.-J.; Yao M.; Ko B.-S.; Li C.-C.; Hsu C.-A.; JIH-LUH TANG; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:21Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; JIH-LUH TANG |
| 臺大學術典藏 |
2021-01-06T03:58:20Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; Tien F.-M.; JIH-LUH TANG; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:19Z |
Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome
|
Huang H.-H.; Chen F.-Y.; Chou W.-C.; Hou H.-A.; Ko B.-S.; Lin C.-T.; JIH-LUH TANG; Li C.-C.; Yao M.; Tsay W.; Hsu S.-C.; Wu S.-J.; Chen C.-Y.; Huang S.-Y.; Tseng M.-H.; Tien H.-F.; Chen R.-H. |
